Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Opko Health Inc (OPK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,292,762
  • Shares Outstanding, K 615,601
  • Annual Sales, $ 990,270 K
  • Annual Income, $ -153,040 K
  • 60-Month Beta 1.81
  • Price/Sales 1.24
  • Price/Cash Flow N/A
  • Price/Book 0.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.11
  • Number of Estimates 2
  • High Estimate -0.10
  • Low Estimate -0.11
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -175.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.92 +9.37%
on 05/15/19
2.50 -16.00%
on 05/06/19
-0.30 (-12.50%)
since 04/18/19
3-Month
1.92 +9.37%
on 05/15/19
2.88 -26.96%
on 02/26/19
-0.64 (-23.36%)
since 02/21/19
52-Week
1.92 +9.37%
on 05/15/19
6.40 -67.19%
on 07/17/18
-1.62 (-43.55%)
since 05/21/18

Most Recent Stories

More News
Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories

BioReference Laboratories, Inc., an OPKO Health company, along with its specialty women's health division, GenPath, today announces the launch of new testing for aerobic vaginitis (AV).

OPK : 2.10 (+5.53%)
Do Options Traders Know Something About OPKO Health (OPK) Stock We Don't?

Investors need to pay close attention to OPKO Health (OPK) stock based on the movements in the options market lately.

OPK : 2.10 (+5.53%)
OPKO Health (OPK) Reports Loss in Q1, Misses Revenue Estimates

Lower revenues, weak performing product segment and contraction in gross margin impact OPKO Health's (OPK) Q1 results.

SYK : 185.45 (+0.62%)
OPK : 2.10 (+5.53%)
XRAY : 54.92 (+0.90%)
CNMD : 80.65 (+0.79%)
Bet on Top Stocks With Rising P/E to Enjoy Solid Gains

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

JWN : 37.85 (+1.04%)
TVTY : 19.00 (+4.11%)
CI : 154.66 (+0.64%)
OPK : 2.10 (+5.53%)
BMY : 47.43 (+2.42%)
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of -100.00% and -9.97%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

OPK : 2.10 (+5.53%)
OPKO Health: 1Q Earnings Snapshot

MIAMI (AP) _ Opko Health Inc. (OPK) on Tuesday reported a loss of $80.8 million in its first quarter.

OPK : 2.10 (+5.53%)
OPKO Health Reports 2019 First Quarter Business Highlights and Financial Results

OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2019.

OPK : 2.10 (+5.53%)
BioReference Laboratories to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions

BioReference Laboratories, Inc., an OPKO Health Company, along with its women's health division GenPath, today announced the presentation of new research from its prenatal and hereditary cancer assessment...

OPK : 2.10 (+5.53%)
BioReference Laboratories Recognized by Forbes as Best Large Employer of 2019

BioReference Laboratories, Inc., an OPKO Health Company (NYSE:OPK), is pleased to announce it has been recognized by Forbes as one of America's Best Large Employers of 2019. This list includes 500 large...

OPK : 2.10 (+5.53%)
Future Demand Of Prostate Cancer Diagnostics Market Are Growing Rapidly In Industry MDxHealth, 3D Signatures, Genomic Health, Abbott, OPKO Health, INC., Siemens Healthcare GmbH

The is anticipated to grow in the forecast period owing to driving factors such as increasing prevalence of disease requiring surgical treatment, Increasing prevalence of Cancer and Hernia and growing...

MXDHF : 1.5000 (-6.25%)
SIEGY : 59.9900 (+1.92%)
GHDX : 56.28 (+3.04%)
DXD.VN : 0.040 (unch)
OPK : 2.10 (+5.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade OPK with:

Business Summary

OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.

See More

Key Turning Points

2nd Resistance Point 2.17
1st Resistance Point 2.13
Last Price 2.10
1st Support Level 2.03
2nd Support Level 1.97

See More

52-Week High 6.40
Fibonacci 61.8% 4.69
Fibonacci 50% 4.16
Fibonacci 38.2% 3.63
Last Price 2.10
52-Week Low 1.92

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar